Comparison of Psychotherapy Programs to Treat Panic Disorder - NCT00353470-10021 (Clinical Trial 146694)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy146694.aspx
|
** Please review additional "Nearby Studies" on right ----->
This is an archived study that is no longer available, if you
would like to find active studies please
search our studies.
|
|
 |
 |
|
| City: |
|
New York |
|
State:
|
|
NY |
| Zip Code: |
|
10021 |
| Conditions: |
|
Anxiety Disorders - Panic Disorder - Agoraphobia |
| Purpose: |
|
This study will determine the relative effectiveness of three psychotherapies in treating
people with a panic disorder.
|
| Study summary: |
|
Panic disorder (PD) is a debilitating anxiety disorder. It is characterized by unexpected
and repeated episodes of intense fear, accompanied by serious physical symptoms, such as
chest pain, heart palpitations, shortness of breath, dizziness, or abdominal stress.
Available treatments for PD include medication therapy and cognitive behavioral therapy
(CBT), a type of psychotherapy that teaches people how to view panic attacks differently and
how to reduce anxiety. Approximately 30% of patients refuse medication, however, and nearly
50% do not achieve remission with CBT alone. Therefore, there is a pressing need for
additional non-pharmacologic treatment methods. Panic-focused psychodynamic psychotherapy
(PFPP) and applied relaxation training (ART) are among some of the other available
treatments for PD. During ART, individuals are taught to relax their muscles while being
exposed to increasingly frightening situations. PFPP combines elements of CBT with other,
more extensive approaches aimed at determining the anxiety's origin and at finding ways to
reduce it. This study will compare the effectiveness of PFPP, CBT, and ART in treating PD.
Participants in this single blind study will be randomly assigned to receive PFPP, CBT, or
ART for 12 weeks. All participants will attend between 19 and 24 treatment sessions over the
course of the study. Upon completing the study, participants will attend monthly follow-up
visits for an additional 12 months. Participants assigned to ART who have not responded by
the end of treatment may opt to receive PFPP or CBT. Outcomes will be assessed using a
variety of scales to determine depression and anxiety symptoms. |
| Criteria: |
|
Inclusion Criteria:
- Meets DSM-IV diagnosis criteria for primary PD with or without agoraphobia
- History of at least one spontaneous panic attack per week within the month prior to
study entry
Exclusion Criteria:
- Active substance dependence within 6 months prior to study entry
- Lifetime history of any psychotic disorder, including bipolar disorder
- Acutely suicidal |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 1, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|